Literature DB >> 28928657

Colocynth Extracts Prevent Epithelial to Mesenchymal Transition and Stemness of Breast Cancer Cells.

Kaushik Chowdhury1, Ankit Sharma1, Suresh Kumar1, Gyanesh K Gunjan1, Alo Nag2, Chandi C Mandal1.   

Abstract

Modern treatment strategies provide better overall survival in cancer patients, primarily by controlling tumor growth. However, off-target and systemic toxicity, tumor recurrence, and resistance to therapy are still inadvertent hurdles in current treatment regimens. Similarly, metastasis is another deadly threat to patients suffering from cancer. This has created an urgent demand to come up with new drugs having anti-metastatic potential and minimum side effects. Thus, this study was aimed at exploring the anti-proliferative and anti-metastatic potential of colocynth medicinal plant. Results from MTT assay, morphological visualization of cells and scratch assay indicated a role of ethanol and acetone extracts of fruit pulp of the colocynth plant in inhibiting cell viability, enhancing cell cytotoxicity and preventing cell migration in various cancer cell types, including breast cancer cell lines MCF-7 and MDA-MB-231, and cervical cancer cell line SiHa, subsequently having a low cytotoxic effect on mononuclear PBMC and macrophage J774A cells. Our study in metastatic MDA-MB-231 cells showed that both ethanol and acetone pulp extracts decreased transcript levels of the anti-apoptotic genes BCL2 and BCLXL, and a reverse effect was observed for the pro-apoptotic genes BAX and caspase 3. Additionally, enhanced caspase 3 activity and downregulated BCL2 protein were seen, indicating a role of these extracts in inducing apoptotic activity. Moreover, MDA-MB-231 cells treated with both these extracts demonstrated up-regulation of the epithelial gene keratin 19 and down-regulation of the mesenchymal genes, vimentin, N-cadherin, Zeb1 and Zeb2 compared to control, suggesting a suppressive impact of these extracts in epithelial to mesenchymal transition (EMT). In addition, these extracts inhibited colony and sphere formation with simultaneous reduction in the transcript level of the stemness associated genes, BMI-1 and CD44. It was also found that both the plant extracts exhibited synergistic potential with the chemotherapeutic drug doxorubicin to inhibit cancer viability. Furthermore, GC-MS/MS analysis revealed the presence of certain novel compounds in both the extracts that are responsible for the anti-cancer role of the extracts. Overall, the results of this report suggest, for the first time, that colocynth fruit pulp extracts may block the proliferative as well as metastatic activity of breast cancer cells.

Entities:  

Keywords:  apoptosis; cancer; cell death; cell viability; colocynth; epithelial to mesenchymal transition; metastasis

Year:  2017        PMID: 28928657      PMCID: PMC5591978          DOI: 10.3389/fphar.2017.00593

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


Introduction

Cancer constitutes a group of deadly diseases that is not only the second leading cause of death worldwide, but also largely contributes to the global health economic burden. The World Health Organization (WHO) has estimated over 14.1 million cancer cases and 8.2 million cancer-induced deaths worldwide in 2012, and this number is expected to rise catastrophically in the coming decades (Torre et al., 2015). Breast and cervical cancers are the most frequently diagnosed cancers in females nationwide, accounting for about 1.7 million new cases and 521,900 breast cancer deaths in 2008 (Torre et al., 2015). India infamously boasts of a surmounting 27 and 23% breast and cervical cancer incidence respectively[1]. Cervical cancer is the second most diagnosed cancer and third leading cause of deaths in females, accounting for about 527600 new cases and 265700 deaths (Torre et al., 2015). Cancer is predominantly caused due to abnormalities in the genome (Balmain et al., 2003) and epigenome (Feinberg and Tycko, 2004) due to exposure to various damaging agents. This set of accumulated cells that has escaped the normal regulatory control mechanisms undergoes unchecked proliferation to form tumors. Despite several advancements in recent years, contemporary anticancer therapy suffers from several limitations owing to their associated toxicity and off-target effects. This provokes an urgent need to design novel drugs with high efficacy specific for cancer cells and less toxicity to off-target cells. Phytochemicals have shown promise in this regard as they fit the above criteria, and their usage in anticancer therapy is an emerging trend. Citrullus colocynth (L.) is a valuable cucurbit plant, widely distributed in the desert areas of the world, including India, known to possess nutritional values and diverse medicinal activities, including antibacterial, antifungal, larvicidal and anti-inflammatory properties (Sawaya et al., 1986; Marzouk et al., 2010; Chawech et al., 2017). Literature documents the presence of many bioactive compounds, such as cucurbitacin, phenolic acids, flavonoids, pyridine and quinolone type alkaloids and fatty acids in fruits of these herbal plants (Hussain et al., 2013, 2014; Jeon and Lee, 2014). This plant is traditionally used to control diabetes (Shi et al., 2014). Recent clinical trial studies have witnessed a fall in fasting blood glucose and Hb1Ac, triglyceride and cholesterol in case of colocynth users (Rahbar and Nabipour, 2010; Barghamdi et al., 2016). Intriguingly, a study by Tannin-Spitz et al. (2007) documented cancer specific apoptotic activity of the isolate cucurbitacin, extracted from this plant. However, no study has yet been conducted to explore the effect of colocynth extract in cancer metastasis. Thus, this study was primarily aimed at investigating the unexplored anti-metastatic potential of this plant extract. This study testified that ethanol and acetone fruit pulp extracts exhibited impressive inhibition of cell viability and cell migration of various cancer cell types, including breast and cervical cancer cells with considerably less effect on mononuclear cells and macrophage cells. Moreover, these pulp extracts noticeably hindered colony and sphere formation and epithelial to mesenchymal transition (EMT) of metastatic breast cancer MDA-MB-231 cells. Our GC-MS analysis also reveals some unique compounds, which may account for the anticancer activity of the extracts. The current study is the first report advocating that fruit pulp extracts containing the novel compounds may have anti-metastatic potential along with apoptotic activity.

Materials and Methods

Materials

Verso cDNA synthesis kit (AB1453A, Thermo Scientific), TRIzol Reagent (T9424, Sigma Aldrich), Taq Polymerase (MBT060A, Himedia), ready Mix dNTP (MBT078, Himedia), caspase-3 antibody (#9661, Cell signaling), BCL-2 antibody (SC-7382, Santa Cruz Technology), actin antibody (A02066, Sigma Aldrich), WesternSure-Premium Chemiluminescent substrate (WesternSure-Li-COR-Part No: 926-95000).

Cell Lines

The human breast cancer MDA-MB-231 (metastatic) and MCF-7 (non-metastatic) cell lines, and cervical cancer SiHa cell line were procured from NCCS cell repository, Pune, India. J774A cell (Macrophage cell line) was obtained from Dr. Vijay Kumar Prajapati, Department of Biochemistry, Central University of Rajasthan, India. All cells were cultured in Dulbecco’s Modified Eagles Medium (DMEM), supplemented with 10% fetal bovine serum (FBS) (RM1112, Himedia) and maintained at 37°C in a humidified incubator with 5% CO2.

Isolation of Human Mononuclear Cells (PBMC)

Mononuclear cells were isolated from human peripheral blood by using a simple and rapid density gradient centrifugation technique using Ficoll-Paque (Sigma-F5414-50ML) methodology established by Boyum (1968) and Boyum (1976). The isolation was done according to the manufacturer’s protocol. Cells (0.5 × 105 cells) were seeded in 96 well culture plate in DMEM supplemented with 10% FBS and incubated for overnight at 5% CO2, and treated with increasing concentration (mentioned in other cell lines) by ethanolic and acetone plant extracts respectively for 24 h. Blood samples from two healthy volunteers were taken and mixed before isolation of PBMC. Written consent was obtained from the participants, and they were informed about the use of blood in this study. Moreover, the work related to blood samples had been conducted by following the regulation of Institutional Ethical Committee at Central University of Rajasthan and, this study was approved by Institutional Ethical Committee.

Plant Extracts

The plant Citrullus colocynth was obtained from a rural area of India [Jaisalmer (26.9157° N, 70.9083° E), Rajasthan, India]. The taxonomic name of this plant had been confirmed by Dr. Amit Kotia, Department of Botany, University of Rajasthan, India. The pulp was isolated from fruits, dried and crushed, using a mixer grinder. One gram of dried pulp powder was suspended in 10 ml of ethanol and acetone, followed by solvent extraction at 50°C for 72 h. The solvent fractions were evaporated using a rotary-evaporator at 42°C to get the crude products. The crude extracts obtained were then dissolved in ethanol and acetone and kept at -20°C for further use.

MTT Cell Viability Assay

Cell viability was measured by MTT assay (MB186, Himedia) described earlier (Ghosh-Choudhury et al., 2010; Mehta et al., 2015). In brief, cancer cells (5000 cells/well) were seeded in 96 well tissue culture plate in DMEM supplemented with 10% FBS at an atmosphere of 5% CO2 at 37°C. After 24 h of seeding, cells were separately incubated with different concentrations [25, 100, and 250 μg/ml; equivalent to 1, 4, and 10 μl of solvents (ethanol/acetone)] of fruit pulp ethanol extract (PEE) and pulp acetone extract (PAE) for 24 h. Control cells were similarly incubated with equal volume of the solvents as in the experimental wells. At the end of the incubation period, 10 μl of MTT solution (5 mg/ml) was added to each well and the plate was incubated at 37°C for 1 h. The formazan crystals formed were solubilized by adding DMSO, and subsequently, absorbance was measured at a wavelength of 530 nm (Studzinski, 1995; Moongkarndi et al., 2004; Ghosh-Choudhury et al., 2010; Mehta et al., 2015). The effective absorbance was calculated for the experimental wells with respect to corresponding control wells. LC50 (Lethal concentration at which 50% cells are killed) at 24 h duration was calculated using MTT data set for different cancer cell lines (Zhang et al., 2007).

Scratch Assay

Cell migration was determined by scratch assay as described earlier (Mandal et al., 2010b, 2011b). In brief, cells (2 × 105 cells/plate) were seeded in 35 mm tissue culture plates and allowed to grow till they reach 95% confluency. A cell scratch-wound was generated using a micropipette tip, and washed once with PBS buffer to remove the floating cells. Cells were then separately treated with PEE and PAE (25 μg/ml) for 24 h in experimental plates, and equal volume of respective solvents was added in control plates. Cells were visualized under an inverted microscope (Carl-Zeiss), and cell migration was assessed by measuring gap sizes in multiple fields and the relative area calculated using ImageJ, and statistically analyzed (Hirsch et al., 2009).

RT-PCR Analysis

Transcript levels of several genes were measured by semi-quantitative RT-PCR analysis as described previously (Mandal et al., 2010a; Chowdhury et al., 2017). In brief, breast cancer cells (2 × 105 cells/plate) were plated in 35 mm tissue culture plates in DMEM supplemented with 10% FBS at an atmosphere of 5% CO2 at 37°C. After 90-100% cell confluency is reached, the cells were treated with different test factors (such as PEE and PAE (50 μg/ml)) for 24 h. Total RNA was extracted using TRIzol reagent as described earlier (Mandal et al., 2010a, 2011a, 2016a; Ghosh-Choudhury et al., 2013). First stand cDNA synthesis was performed using 1 μg of total RNAs using the Verso cDNA synthesis kit, according to manufacturer’s instruction. Semi-quantitative PCR was performed using this cDNA as template and gene specific primers in a ProFlex PCR system (Applied Biosystem by Life Technologies). The list of primers used in this study is given in Supplementary Table S1. Densitometric analysis of the PCR bands was done using ScnImage (Chowdhury et al., 2017).

Western Blot Analysis

Methodology of western blotting has been described previously (Chowdhury et al., 2017). In brief, cells were seeded at a density of 2 × 105 cells/plate in 35 mm tissue culture plates. Cells were treated with different test factors and harvested after 24 h of treatment. Protein extraction was carried out in RIPA buffer and subsequently, cell lysates were centrifuged at 12,000 × g at 4°C for 20 min. The protein concentration was measured by Bradford reagent (BIORAD), according to manufacturer’s instruction. Equal amounts of whole cell lysates were resolved by 12% SDS-PAGE, and transferred to PVDF membrane. This PVDF membrane was incubated with primary antibody (Anti-caspase-3 antibody (#9661, Cell signaling), Anti-BCL-2 antibody (SC-7382, Santa Cruz Technology), Anti-actin antibody (A02066, Sigma Aldrich) used at 1:1000 dilution) overnight at 4°C. After washing, the PVDF membrane was further incubated with HRP-conjugated secondary antibody (used at 1:10000 dilution) for 1 h at room temperature. The washed membrane was further incubated with chemiluminescent substrate and subsequently, the blot was scanned by C-DIGIT Blot Scanner (Li-COR-Model: 3600).

Colony Formation Assay

Cells were seeded at a density of 500 cells/well in a 12 well tissue culture plate in DMEM with 10% FBS at 37°C incubator with 5% CO2 for 24 h. Cells were then treated with PEE and PAE extracts (25 μg/ml), and incubated under same conditions for 5 days. Next, colonies were fixed with methanol and were stained with crystal violet solution (Hirsch et al., 2009). Photographs of stained plate were taken by a camera. Photographs of colonies were also taken by a bright field inverted microscope (Carl-Zeiss).

Soft Agar Sphere Formation Assay

For performing soft agar assay (Sebolt-Leopold et al., 1999), MDA-MB-231 cells (10,000 cells/plate) were mixed with 2X DMEM containing 0.6% (w/v) agar and layered with 2X DMEM containing 1.2% base agar medium in 35 mm culture plates. 25 μg/ml of PEE and PAE was added in 300 μl of DMEM to the top agar and cells were allowed to grow for 8 days. The top 300 μl medium was replaced with fresh medium with or without test factors at intervals of every 3 days. The morphology and size of the spheres were visualized using bright field inverted microscope (Carl-Zeiss) and photographed. Subsequently, spheres were manually counted under the microscope.

GC-MS/MS Analysis

Solvent Extraction of Citrullus colocynthis fruit pulp was done by ethanol and acetone. Dried extracts were dissolved in methanol followed by GC-MS/MS analysis using Thermo GC 1300 and “TSQ 8000” Triple quadrupole GC-MS/MS SYSTEM with auto sampler Al 1310. The Gas Chromatography 1300 was used with a fused GC column TG-5MS AMINE. The column length was of 30 m with an internal diameter coated film of 0.25 μm, with the flow rate of 10 ml/min and the condition kept were as follows: PTV Temp. Program: 70°C, hold 2.00 min, 10°C/min to 270°C, hold 8 min. Carrier gas helium flow rate was 1 ml/min and split ratio of 1:50. GC was equipped with an auto sampler AI 1300 and sample volume loaded was 1 μl. Eluates were automatically passed into the mass spectrometer. Mass Spectrum analysis was conducted using TSQ-8000 with a transfer line temperature of 280°C and ion source temperature of 230°C in EI mode. Mass scan time was 4 min with feature of full Scan MS. The mass spectrum was also equipped with a computer fed NIST mass Spectra data library.

Component Identification

Chemical constituents of the extracts were identified by matching the peaks with Computer NIST MS libraries and confirmed by comparing mass spectra of the peaks and those from literature. List of 50 compounds isolated from the extracts are listed in Supplementary Tables S2, S3. Scifinder was used to analyze the compounds and thus interpret the literature available for them.

Statistical Analysis

Statistical analysis was done by GraphPad Prism (Ghosh-Choudhury et al., 2010; Mandal et al., 2011a,b, 2016b). A p-value of < 0.05 was considered to be statistically significant. All values were represented as mean ± standard error mean of three measurements.

Results

Effect of Colocynth Fruit Pulp Extracts on Viability of Breast and Cervical Cancer Cells

To test the anticancer potential of colocynth fruit pulp extracts (prepared separately by solvent ethanol and acetone), cell viability was measured by MTT assay. For this, different cancer cells, including breast cancer cell lines, MCF-7 and MDA-MB-231, and cervical cancer cell line, SiHa, were separately treated with increasing concentrations (range 25–250 μg/ml) of PEE and PAE for 24 h (Figures –, ). MTT assay result showed noteworthy reduction in the number of viable cells in a dose dependent manner for both PEE and PAE treatment when compared to their respective solvent controls. To determine the effectiveness of the pulp extracts in these cancer cells, LC50 values (using MTT data) were also calculated. In case of ethanol extract, LC50 (μg/ml) values were 142 ± 16, 105 ± 8.3 and 157 ± 4.3 for MDA-MB-231, MCF-7 and SiHa cell lines respectively (Table ). For acetone extract, these values were 140 ± 0.8, 94 ± 6.4 and 121 ± 4.6 respectively. These findings indicated relatively higher efficacy of PAE in cancer cell lines compared to PEE. Moreover, MCF-7 cells showed higher sensitivity to both PAE and PEE as compared to MDA-MB-231 cells. LC50 values of both the extracts in PBMC and J774A cell line were >300 μg/ml (Table ). Furthermore, microscopic visualization indicated a cytotoxic effect of the extracts upon these cancer cell lines (Figures , ). All these findings suggested that the fruit pulp extracts induced reduced viability of cells that is presumably caused by inhibiting cell proliferation and inducing cytotoxicity. Effect of fruit pulp ethanol extract of colocynth on cell viability and cytotoxicity of breast and cervical cancer cell lines. Cell viability was measured by MTT assay after 24 h of treatment of breast cancer MDA-MB-231 (A) and MCF-7 (B), and cervical SiHa (C) cell lines with pulp ethanol extract (PEE) with different concentrations (25–250 μg/ml). Values represent mean ± SE of triplicate measurements, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 vs. control. (D–F) Morphologic visualization (cytotoxicity) was recorded after 24 hr of treatment of breast cancer MDA-MB-231 (D) and MCF-7 (E), and cervical SiHa (F) cell lines with PEE (100 μg/ml). Photographs were taken at 10X magnification. Effect of fruit pulp acetone extract of colocynth on cell viability and cytotoxicity of breast and cervical cancer cell lines. MTT assay was performed to measure cell viability by after 24 h of treatment of breast cancer MDA-MB-231 (A) and MCF-7 (B), and cervical SiHa (C) cell lines with pulp acetone extract (PAE) with different concentrations (25–250 μg/ml). Values represent mean ± SE of triplicate measurements, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001, vs. control. (D–F) Morphologic visualization (cytotoxicity) was recorded after 24 h of treatment of breast cancer MDA-MB-231 (D) and MCF-7 (E), and cervical SiHa (F) cell lines with PAE (100 μg/ml). Photographs were taken at 10X magnification. Cytotoxic effect [LC50 (μg/ml)] of Citrullus colocynthis pulp extracts against two breast cancer (MDA-MB-231 and MCF-7), a cervical cancer (SiHa) cell lines, a human mononuclear cell PBMC and a macrophage cell J774A. To examine the influence of these pulp extracts on cell apoptosis, RT-PCR analysis was performed to compare the transcript levels of anti-apoptotic BCL2 and BCLXL and apoptotic BAX genes, using total RNA of MDA-MB-231 cells with or without treatment with ethanol and acetone extracts (50 μg/ml). Both PEE and PAE considerably impeded BCL2 and BCLXL expression with simultaneous upsurge in BAX expression (Figures and Supplementary Figures S1A–C,E–G). Moreover, expression of apoptotic caspase 3 gene was augmented upon treatment with both PAE and PEE (Figures and Supplementary Figures S1D,H). Furthermore, western blot results demonstrated increased level of cleaved caspase 3 (Figures ) with a concomitant decrease in the protein level of anti-apoptotic gene BCL2 (Figures ) for both ethanol and acetone extract treated cells compared to control. These observations led us to propose an apoptotic activity of fruit pulp extracts in breast cancer cells. Effect of fruit pulp extracts on anti-apoptotic and apoptotic genes in MDA-MB-231 cells. (A) Cells were separately treated with pulp ethanol extract (PEE) (A,C,E,G) and pulp acetone extract (PAE) (B,D,F,H) for 24 h, and subsequently expression of anti-apoptotic genes (A,B) BCL2 and BCLXL, and pro-apoptotic genes BAX (C,D) and Caspase 3 (E,F) were measured by RT-PCR analysis, using total RNA isolated from cells with or without PEE and PAE treatment, and gene specific primers. Here, GAPDH was used as an internal loading control. Densitometric analysis data are given in Supplementary Figure S1. (G,H) Level of cleaved caspase 3 and (I,J) BCL-2 was measured by western blotting using equal amount of cellular protein isolated from cells with or without treatment with PEE or PAE. B-actin serves as an internal loading control.

Inhibitory Effect of Colocynth Pulp Extracts on Cancer Cell Migration

A common problem faced by a large percentage of cancer patients is development of metastasis if cancers are not detected in early and/or not treated with a suitable therapy. Migration of cancer cells is a critical step in the metastatic cascade (Chaffer and Weinberg, 2011). Thus, we investigated the effect of pulp ethanol and acetone extracts on the migratory property of cancer cells by performing scratch assay. Scratches were made on cell monolayer by a small pipet tip, and subsequently, cells were incubated with or without pulp extracts. Microscopic photos indicated migration of cells to close the induced scratch after 24 h in control MDA-MB-231, MCF-7 and SiHa cells (Figures , ). Cells treated with both ethanol and acetone extracts (25 μg/ml) showed substantial prevention of cell migration as evident from the unfilled gap areas between the two ends of the scratches that were larger in cases of pulp extracts as compared to control. The data displayed in Figures , denoted a significant inhibition of cell migration in response to treatment with both ethanol and acetone extracts. Pulp ethanol extract inhibited migration of breast and cervical cancer cells. Breast cancer MDA-MB-231 (A), MCF-7 (B) and cervical cancer (SiHa) (C) cells were treated with pulp ethanol extract (PEE) for 24 h. Photos of cells at the starting time point and after 24 h of treatment were captured by inverted bright field microscope. The unfilled gap areas between two ends of the scratch were measured and subsequently plotted. Significant inhibition of cell migration was observed in case of PEE treated plates wells as compared to control in MDA-MB-231 (D), MCF-7 (E) and SiHa (F) cancer cell lines. Percent inhibition by PEE after 24 h was calculated with the 0 h being the control. Values represent mean ± SE of triplicate measurements. In (D) ∗∗∗∗p < 0.0001; control (ethanol) 24 h vs. control (ethanol) 0 h and ∗∗∗∗p < 0.0001; PEE 24 h vs. control 24 h. In (E) ∗∗∗∗p < 0.0001; control (ethanol) 24 h vs. control (ethanol) 0 h and ∗∗∗∗p < 0.0001; PEE 24 h vs. control (ethanol) 24 h. In (F) ∗∗p < 0.01; control (ethanol) 24 h vs. control (ethanol) 0 h and ∗∗p < 0.01; PEE 24 h vs. control (ethanol) 24 h. Pulp acetone extract inhibited migration of breast and cervical cancer cells. Breast cancer MDA-MB-231 (A), MCF-7 (B) and cervical cancer (SiHa) (C) cells were treated with pulp acetone extract (PAE) for 24 h. Photos of cells at the starting timepoint and after 24 h of treatment were captured by inverted bright field microscope. The unfilled gap areas between two ends of the scratch were measured and subsequently plotted. Significant inhibition of cell migration was observed in case of PAE treated plates wells as compared to control in MDA-MB-231 (D), MCF-7 (E) and SiHa (F) cancer cell lines. Percent inhibition by PAE after 24 h was calculated with the 0 h being the control. Values represent mean ± SE of triplicate measurements. In (D) ∗∗∗∗p < 0.0001; control (acetone) 24 h vs. control (acetone) 0 h and ∗∗∗p < 0.001; PAE 24 h vs. control (acetone) 24 h. In (E) ∗∗∗∗p < 0.0001; control (acetone) 24 h vs. control (acetone) 0 h and ∗∗∗∗p < 0.0001; PAE 24 h vs. control (acetone) 24 h. In (F) ∗∗p < 0.01; control (acetone) 24 h vs. control (acetone) 0 h. and ∗∗p < 0.01; PAE 24 h vs. control (acetone) 24 h.

Effect of Colocynth Pulp Extracts on EMT

Transition from epithelial to mesenchymal phenotype is a critical step for metastasis (Chaffer and Weinberg, 2011). To examine the effect of fruit pulp extracts on prevention of EMT of metastatic MDA-MB-231 cells, we analyzed mRNA levels of several EMT markers by RT-PCR. Interestingly, we observed a decline in expression of mesenchymal markers, Vimentin and N-cadherin, with a concurrent increase in the expression of epithelial marker keratin-19 in treated samples (Figures and Supplementary Figures S2A–C,F–H). Moreover, both PEE and PAE treatment strongly inhibited expression of the mesenchymal phenotype inducing transcription factors, Zeb1 and Zeb2 (Figures and Supplementary Figures S2D,E,I,J). These observations clearly indicate a restraining impact of these pulp extracts on EMT of breast cancer cells. Effect of colocynth pulp extracts on expression of EMT associated genes in breast cancer cells. Breast cancer MDA-MB-231 cells were either treated with pulp ethanol extract (PEE) (A) or pulp acetone extract (PAE) (B) for 24 h, and subsequently the expression of EMT associated genes was measured by RT-PCR analysis using total RNA isolated from cells. GAPDH was used an internal loading control. Densitometric data is given in Supplementary Figure S2.

Colocynth Pulp Extracts Inhibited Stemness Property of Breast Cancer Cells

Accumulating evidences suggest that cancers develop from cancer initiating cells or cancer stem cells (CSCs) (Reya et al., 2001; Singh and Settleman, 2010). Although CSCs comprise of a small percentage of the tumor population, their resistance to contemporary chemo- and radiation- therapy is a leading cause for tumor recurrence and metastasis (Li et al., 2007; Singh and Settleman, 2010). Thus, we investigated the effect of colocynth pulp extracts on the stemness property of metastatic MDA-MB-231 cells by colony formation assay. In agreement with previous observations, the number of colony formed was markedly reduced when cells were treated with pulp extracts (25 μg/ml) as compared to control, indicating an inhibitory role of both PEE and PAE on cancer stemness (Figures ). To further support these results, we carried out soft agar sphere formation assay. Microscopic visualization documented formation of a great number of spheres with large size after 8 days of cell culture in the control plates. The number as well as the size of such spheres was, however, greatly diminished when cells were incubated with both PAE and PEE (25 μg/ml) as compared to control (Figures ). These results show that fruit pulp extracts might attenuate stemness property of cancer cells. To verify these findings, we further examined the effect of these pulp extracts on the expression of stemness associated genes CD44 and BMI-1. RT-PCR analysis documented that transcript levels of both CD44 and BMI-1 genes (Al-Hajj et al., 2003; Liu et al., 2006) were significantly lowered in MDA-MB-231 cells when treated with both PAE and PEE as compared to control (Figures and Supplementary Figures S3A–D). Together, these data clearly suggested that fruit pulp extracts (PEE and PAE) obliterate the stemness property of breast cancer cells. Effect of colocynth pulp extracts on colony formation of breast cancer cell. MDA-MB-231 cells were treated with pulp ethanol extract (PEE) (A,C) and pulp acetone extract (B,D). After 5 days of cell seeding, photos of the wells were taken by a camera (A,B), and colonies were also visualized by inverted bright field microscope (C,D). Inhibitory activity of colocynth pulp extract on spheroid formation and stemness of breast cancer cell. (A) Soft agar assay was performed on MDA-MB-231 cells by treating cells with pulp ethanol extract (PEE; A,C) and pulp acetone extract (PAE; B,D) and allowing cells to grow for 8 days. Spheroid colonies were visualized by inverted bright field microscope (A,B). Number of spheroids of all plates was counted and analyzed with respect to control plates (C,D), in (C) ∗∗p < 0.01; PEE vs. control (ethanol) after 8 days, and in (D) ∗∗p < 0.01; PAE vs. control (acetone) after 8 days. (E,F) MDA-MB-231 cells were treated with PEE (E) and PAE (F) for 24 h and subsequently, expression of CD44 and BMI-1 was compared by RT-PCR analysis using total RNA isolated from cells and CD44 and BMI-1 gene specific primers. GAPDH was used as an internal loading control. Densitometric data is given in Supplementary Figure S3.

Discussion

Considering the current status of diagnostic and treatment options available, cancer associated deaths are on the rise. In India, carcinoma of the breast and cervix contributes to 50% of total cancer incidences[2]. However, surgical removal, radiation-, chemo-, endocrine-, and other targeted- therapies are continuously being improvised to improve the overall survival and quality of life of cancer patients. Although modern treatment modalities are capable of taking care of the primary tumors, tumor recurrence and metastasis are the major limitations in the limelight at present. Furthermore, chemotherapeutic drugs often show significant off-target effects along with systemic toxicity, such as cardiovascular, liver and nephrotoxicity (King and Perry, 2001; Schimmel et al., 2004). Thus, finding novel anticancer drugs, which prevent both tumor growth and metastasis while circumventing the known side effects, is an active area of research. In this area, application of natural products like secondary metabolites with effective tumor suppressive ability has shown promise in recent years as they are found to be effective even at sufficiently lower doses and due to their safety profile (Koehn and Carter, 2005). Thus, this study was aimed at exploring the anti-cancer properties of extracts from Citrullus colocynth plant of the cucurbitaceae family that has been used as a traditional medicine to control diabetes (Zaini et al., 2011; Shi et al., 2014). Reports about the nutritional and medicinal values of this plant and presence of many bioactive molecules had initially attracted our attention (Sawaya et al., 1983, 1986; Asyaz et al., 2010; Marzouk et al., 2010; Hussain et al., 2013, 2014; Jeon and Lee, 2014; Chawech et al., 2017). Moreover, Tannin-Spitz et al. (2007) found that an isolate (cucurbitacin glucosides) extracted from the leaves of this plant exhibits apoptotic activity in cancer cells. Nevertheless, no detailed study was done regarding the anti-cancer effects of this plant extract. Our study found that both ethanol and acetone extracts of fruit pulp of the colocynth plant showed a significant inhibition of cell viability of various cancer cell lines, including breast cancer MCF-7 and MDA-MB-231, and cervical cancer SiHa cell lines (Figures , and Table ). Correspondingly, both extracts had reverse cytotoxic effect on mononuclear cells PBMC and macrophage cell line J774A. Breast cancer MCF-7 cells showed more sensitivity to both ethanol and acetone pulp extracts as compared to other cancer cells. This was in agreement with previous reports that too claim higher sensitivity of MCF-7 cells to colocynth fruit extract at relatively lower concentrations (Mukherjee and Patil, 2012). The probable explanation may be either use of alkaloid rich extracts or longer exposure in MCF-7 cells (Mukherjee and Patil, 2012). Our study also found that both ethanol and acetone extracts exhibited synergistic potential with the chemotherapeutic drug doxorubicin to inhibit viability in the breast cancer cells (Supplementary Figure S4). Moreover, on molecular analysis, we found suppression of transcripts of anti-apoptotic genes BCL2 and BCLXL, and an induction of apoptotic gene BAX and caspase 3 mRNA in metastatic breast cancer MDA-MB-231 cells following treatment with ethanol and acetone pulp extracts (Figure ). In addition, these pulp extracts displayed a higher level of cleaved caspase 3 protein and a lower level of BCL-2 protein as compared to control, implying an enhancement of active caspase 3 upon treatment with these extracts (Figure ). Thus, this study indicated that colocynth fruit pulp extracts exhibit an anticancer potential presumably by promoting apoptosis. As stated earlier, metastasis remains one of the major threats to cancer patients. However, no study has yet been conducted to investigate the anti-metastatic potential of this plant extract. Our study indicated, for the first time, a preventive role of these pulp extracts in cancer cell migration, a key step in the metastatic process (Figures , ) (Chaffer and Weinberg, 2011). These pulp extracts also block EMT (Chaffer and Weinberg, 2011), another vital step in the metastatic cascade, since both PEE and PAE treatment significantly enhanced epithelial gene expression with simultaneous inhibition of mesenchymal marker expression in breast cancer MDA-MB-231 cells (Figure ). Additionally, treatment of cancer cells with these ethanol and acetone pulp extracts showed a noticeable reduction in colony and sphere formation with concomitant inhibition of cancer stemness associated genes CD44 and BMI-1 at their transcript levels, suggesting a preventive role of these pulp extracts in cancer stemness (Monteiro and Fodde, 2010), a pivotal property responsible for metastasis, therapy resistance and tumor recurrence (Figures , ). All these findings summarized a role of the ethanol and acetone fruit pulp extracts of colocynth in prevention of cell proliferation, induction of cell apoptosis, prevention of cell migration, reduction of EMT, and inhibition of cancer stemness property in breast cancer cells. However, further study is required to identify the bioactive molecule(s) present in fruit pulp, liable for the observed anticancer potential. Subsequent GC-MS/MS analysis of both the extracts revealed about fifty compounds (Supplementary Figures S5A,B and Tables S2, S3) out of which, we analyzed the top 20 compounds on the basis of abundance in the extracts (Table ). More in-depth study narrowed the list to those compounds that are novel to the extracts, with no previous reports of biological study (Table ). We have also noticed that some compounds are common both in ethanolic and acetone extracts. Thus, purification and more detailed investigation of these compounds will enable identification of the potent constituents in the extracts that are accountable for retarded cell growth and metastasis of cancer cells. Further mechanistic studies will prove extremely useful for their utility in future therapeutic interventions. Top 20 compounds isolated from GC-MS/MS analysis of ethanol and acetone crude extract. List of extracted novel compounds. In brief, using cell culture based in vitro study and GC-MS/MS analysis, we report, for the first time, some novel compounds in the fruit pulp extracts of colocynth plant, that show promising potential as anti-cancer therapeutics for their tumor suppressive properties.

Author Contributions

KC, AS, SK, and GG have substantial contribution in performing experiments, analyzing data, and interpreting results. KC has substantial involvement in drafting manuscript. AN has significant contribution in analyzing data and editing the manuscript. CM has formulated and supervised the work, and written the manuscript. All authors approved the final version of the manuscript and agree to be accountable for the content of this work.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Table 1

Cytotoxic effect [LC50 (μg/ml)] of Citrullus colocynthis pulp extracts against two breast cancer (MDA-MB-231 and MCF-7), a cervical cancer (SiHa) cell lines, a human mononuclear cell PBMC and a macrophage cell J774A.

LC50 (μg/ml) ± SEM

Cancer cell linesNormal cell lines


Solvents (extraction)MDA-MB-231MCF-7SiHaPBMCJ774A
Colocynth fruit pulpEthanol142 ± 16105 ± 8.3157 ± 4.3>300>300
Acetone140 ± 0.894 ± 6.4121 ± 4.6>300>300
Table 2

Top 20 compounds isolated from GC-MS/MS analysis of ethanol and acetone crude extract.

S. NoRTCompound nameArea %Molecular formulaMolecular weightBiological study
Ethanol
120.64Naphtho[1,2-d]oxazol-2(1H)-one, 3a,4,5,9b-tetrahydro-3a,5,5,9b-tetramethyl-1-(phenylmethyl)-31.32C22H25NO2335Not reported
221.641,5-Diphenylhex-3-ene14.72C18H20236Anti-microbial
328.56Benzenesulfonic acid, 4-methoxy-, [(4-methylphenyl)sulfonyl]methyl ester5.56C15H16O6S2356Not reported
424.6Heptyl methyl methylphosphonate4.55C8H19O3P194Not reported
57.58DL-4,5-Octanediol3.28C8H18O2146Not reported
616.99Oxalic acid, allyl dodecyl ester3.23C17H30O4298Yes
721.9710-Pentadecen-5-yn-1-ol, (E)-3.22C15H26O222Not reported
829.33(E,E,E)-(5-Phenylsulfonylgeranyl)geraniol2.71C26H38O3S430Not reported
918.71cis,cis,cis-7,10,13-Hexadecatrienal2.46C16H26O234Yes, anti-microbial
1026.462-Isopropyl-5-methylcyclohexyl 3-(1-(4-chlorophenyl)-3-oxobutyl)-coumarin-4-yl carbonate2.26C30H33ClO6524Not reported
1122.52Cyclopenta[c]pyran-1,3-dione, 4,4a,5,6-tetrahydro-4,7-dimethyl-2C10H12O3180Yes, anti-insecticidal
1226.512-Isopropyl-5-methylcyclohexyl 3-(1-(4-chlorophenyl)-3-oxobutyl)-coumarin-4-yl carbonate1.98C30H33CLO6524Not reported
1313.042,2-Dimethyl-propyl 2,2-dimethyl-propanesulfinyl sulfone1.7C10H22O3S2254Yes
1414.43á-l-Arabinopyranoside, methyl1.59C6H12O5164Yes
158.78Cycloheptatrienylium, iodide1.46C7H7I218Not reported
1618.62Cyclohexanemethyl propanoate1.41C10H18O2170Yes
1720.472,2-Dimethyl-propyl 2,2-dimethyl-propanesulfinyl sulfone1.36C10H22O3S2254Yes
1823.01Benzenesulfonic acid, 4-methoxy-, [(4-methylphenyl)sulfonyl]methyl ester1.33C15H16O6S2356Not reported
1928.31Dimethylsilyl tert-buthylperoxide1.24C6H16O2Si148Not reported
2023.9Heptyl methyl methylphosphonate1.02C9H21O3P208Not reported
Acetone
118.91Oxalic acid, cyclobutyl octadecyl ester24.73C24H44O4396Yes
221.029,12,15-Octadecatrienal16.98C18H30O262Yes
3142,2-Dimethyl-propyl 2,2-dimethyl-propanesulfinyl sulfone14.46C10H22O3S2254Yes
420.91Z-4-Dodecenol10.32C12H24O184Yes
528.95Carbonic acid, 3-hexenyl methyl ester, (Z)-5.24C8H14O3158Yes
623.61Naphtho[1,2-d]oxazol-2(1H)-one, 3a,4,5,9b-tetrahydro-3a,5,5,9b-tetramethyl-1-(phenylmethyl)-4.79C22H25O2335Not reported
724.7417-Octadecene-9,11-diynoic acid, 8-hydroxy-, methyl ester3.36C19H28O3304Not reported
821.131-Cyclohexylnonene2.84C15H28208Not reported
98.71Cycloheptatrienylium, iodide1.24C7H7I218Not reported
1024.64Cyclohexanemethyl propanoate1.2C10H18O2170Yes
1110.13-Selenetanol, 3-(4-methoxyphenyl)-1.12C10H12O2Se244Not reported
127.71Cyclobutanecarboxylic acid, but-3-yn-2-yl ester1.1C10H14O2166Not reported
1323.851-Benzylbenzimidazole 3-oxide0.85C14H12N2O224Yes
1425.86Sucrose0.75C12H22O11342Yes
1529.49-Azabicyclo[6.1.0]nonane, 9,9′-azobis-, [1à,8à,9[E(1’R,8’S)]]-0.75C16H28N4276Not reported
167.77N,N′-Bis(2,6-dimethyl-6-nitrosohept-2-en-4-one)0.7C18H30N2O4338Not reported
1715.63Z-2-Dodecenol0.69C12H24O184Yes
1827.462-(4-Bromobutyl)-furan0.59C8H11BrO202Not reported
1918.582,2-Dimethyl-propyl 2,2-dimethyl-propanesulfinyl sulfone0.58C10H22OS2254Yes
2024.845,10-Pentadecadiyn-1-ol0.55C15H24O220Yes
Table 3

List of extracted novel compounds.

S. NoRTCompound nameArea %Molecular formulaBiological study
Ethanol plant extract
123.84Phosphonic acid, methyl-, 2,2-dimethylcyclohexyl methyl ester0.73C10H21O3PNA
216.342-Trimethylsiloxy-6-hexadecenoic acid, methyl ester0.25C20H40O3SiNA
321.05Manganese(1+), dicarbonyl[(1,2,3,4,5-ü)-1-methyl-2,4-cyclopentadienyl]nitrosyl-0.24C8H8MnNO3NA

120.64Naphtho[1,2-d]oxazol-2(1H)-one, 3a,4,5,9b-tetrahydro-3a,5,5,9b-tetramethyl-1-(phenylmethyl)-31.32C22H25NO2NA
221.642-Cyclohexene-6-carboxylic acid, 3-methyl-1-(5-oxo-3,4-dihydro-2H-pyrrolyl)-, ethyl ester14.72C14H21NO3NA
328.56Naphtho[1,2-d]oxazol-2(1H)-one, 3a,4,5,9b-tetrahydro-3a,5,5,9b-tetramethyl-1-(phenylmethyl)-5.56C22H25NO2NA
418.71Acrylic acid, 5,7-octadien-1-yl ester2.46C11H16O2NA
526.462-Isopropyl-5-methylcyclohexyl 3-(1-(4-chlorophenyl)-3-oxobutyl)-coumarin-4-yl carbonate2.26C30H33ClO6NA
626.514-Chloro-4-methylhexane-2,3-dione1.98C7H11ClO2NA
729.1Cyanomethyl 2-chloroethyl disulfide0.26C4H6ClNS2NA
89.832-Methyl-2-(methoxy-ethoxy)amino-propan-1-ol0.2C7H17NO3NA
925.255-[2-(1,3-Dioxolan-2-yl)-ethyl]-2-methyl-1-cyclopentene-1-carboxaldehyde0.13C12H18O3NA

Acetone plant extract
17.36Propanamide, 3-(3,4-dimethylphenylsulfonyl)-0.31C11H15NO3SNA
27.77Cyclobutanecarboxylic acid, 4-nitrophenyl ester0.7C11H11NO4NA
326.12Bicyclo[3.2.1]octane, 2-bromo-4-iodo-0.22C8H12BrINA

123.61Naphtho[1,2-d]oxazol-2(1H)-one, 3a,4,5,9b-tetrahydro-3a,5,5,9b-tetramethyl-1-(phenylmethyl)-4.79C22H25NO2NA
224.744,5-Dihydroxy-6-hydroxymethyl-oxepan-3-one3.36C7H12O5NA
321.132-Methyl-2-chloro-3-nitroso-4-cyclohexyloxy-butane2.84C11H20ClNO2NA
47.71Cyclobutanecarboxylic acid, but-3-yn-2-yl ester1.1C10H14O2NA
57.71Cyclobutanecarboxylic acid, pent-2-en-4-ynyl ester1.1C10H12O2NA
625.866-Chloro-2,2,9,9-tetramethyl-3,7-decadiyn-5-ol0.75C14H21ClONA
77.77Cyclobutanecarboxylic acid, but-3-yn-2-yl ester0.7C10H14O2NA
826.435-[2-(1,3-Dioxolan-2-yl)-ethyl]-2-methyl-1-cyclopentene-1-carboxaldehyde0.4C12H18O3NA
924.222-Bromoethyl vinyl sulfide0.15C4H7BrSNA
1027.59N-Difluorophosphoxy -O-trimethylsilylhydroxylamine0.15C3H10F2NO2PSiNA
  37 in total

Review 1.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

Review 2.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

Review 3.  The evolving role of natural products in drug discovery.

Authors:  Frank E Koehn; Guy T Carter
Journal:  Nat Rev Drug Discov       Date:  2005-03       Impact factor: 84.694

4.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.

Authors:  Suling Liu; Gabriela Dontu; Ilia D Mantle; Shivani Patel; Nam-shik Ahn; Kyle W Jackson; Prerna Suri; Max S Wicha
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

Review 5.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

6.  Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44.

Authors:  Chandi Charan Mandal; Nayana Ghosh-Choudhury; Toshi Yoneda; Goutam Ghosh Choudhury; Nandini Ghosh-Choudhury
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

7.  Simvastatin and MBCD Inhibit Breast Cancer-Induced Osteoclast Activity by Targeting Osteoclastogenic Factors.

Authors:  Kaushik Chowdhury; Ankit Sharma; Tanu Sharma; Suresh Kumar; Chandi C Mandal
Journal:  Cancer Invest       Date:  2017-05-02       Impact factor: 2.176

Review 8.  The genetics and genomics of cancer.

Authors:  Allan Balmain; Joe Gray; Bruce Ponder
Journal:  Nat Genet       Date:  2003-03       Impact factor: 38.330

9.  Is cholesterol a mediator of cold-induced cancer?

Authors:  Chandi C Mandal; Ankit Sharma; Mahaveer S Panwar; James A Radosevich
Journal:  Tumour Biol       Date:  2016-01-21

10.  Reactive oxygen species derived from Nox4 mediate BMP2 gene transcription and osteoblast differentiation.

Authors:  Chandi C Mandal; Suthakar Ganapathy; Yves Gorin; Kalyankar Mahadev; Karen Block; Hanna E Abboud; Stephen E Harris; Goutam Ghosh-Choudhury; Nandini Ghosh-Choudhury
Journal:  Biochem J       Date:  2011-01-15       Impact factor: 3.857

View more
  8 in total

Review 1.  Abdominal CT manifestations of adverse events to immunotherapy: a primer for radiologists.

Authors:  Ali Pourvaziri; Anushri Parakh; Pierpaolo Biondetti; Dushyant Sahani; Avinash Kambadakone
Journal:  Abdom Radiol (NY)       Date:  2020-09

2.  Berberis lycium fruit extract and its phytoconstituents berberine and rutin mitigate collagen-CFA-induced arthritis (CIA) via improving GSK3β/STAT/Akt/MAPKs/NF-κB signaling axis mediated oxi-inflammation and joint articular damage in murine model.

Authors:  Anamika Sharma; Narendra Vijay Tirpude; Neha Bhardwaj; Dinesh Kumar; Yogendra Padwad
Journal:  Inflammopharmacology       Date:  2022-03-07       Impact factor: 4.473

3.  A case of gastric cancer that developed thrombocytopenia during treatment with nivolumab.

Authors:  Takehiro Kagaya; Naohiko Koide; Yoshinori Koyama; Yuka Kagaya
Journal:  Clin J Gastroenterol       Date:  2021-02-21

4.  A Piscibacillus sp. Isolated from A Soda Lake Exhibits Anticancer Activity Against Breast Cancer MDA-MB-231 Cells.

Authors:  Deepesh Kumar Neelam; Akhil Agrawal; Anuj Kumar Tomer; Shreetama Bandyopadhayaya; Ankit Sharma; Medicharla V Jagannadham; Chandi C Mandal; Pawan K Dadheech
Journal:  Microorganisms       Date:  2019-01-26

5.  Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells.

Authors:  Ankit Sharma; Shreetama Bandyopadhayaya; Kaushik Chowdhury; Tanu Sharma; Rekha Maheshwari; Amlan Das; Gopal Chakrabarti; Vipin Kumar; Chandi C Mandal
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

6.  Solvent fractions of selected Ethiopian medicinal plants used in traditional breast cancer treatment inhibit cancer stem cells in a breast cancer cell line.

Authors:  Nigatu Tuasha; Daniel Seifu; Endalamaw Gadisa; Beyene Petros; Stina Oredsson
Journal:  BMC Complement Med Ther       Date:  2020-11-25

Review 7.  Citrullus colocynthis (L.) Schrad (Bitter Apple Fruit): Promising Traditional Uses, Pharmacological Effects, Aspects, and Potential Applications.

Authors:  Qin-Yuan Li; Mahzaib Munawar; Muhammad Saeed; Ji-Qiang Shen; Muhammad Sajjad Khan; Sobia Noreen; Mahmoud Alagawany; Muhammad Naveed; Asadullah Madni; Chang-Xing Li
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

8.  Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study.

Authors:  E M Presotto; G Rastrelli; I Desideri; V Scotti; S Gunnella; N Pimpinelli; E Vaccher; A Bearz; F Di Costanzo; M Bruggia; E Mini; M Maggi; A Peri
Journal:  J Endocrinol Invest       Date:  2019-09-21       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.